Piramal Pharma Ltd PPLPHARMA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹221.96
- Day Range
- ₹216.30–230.00
- 52-Week Range
- ₹87.50–243.99
- Bid/Ask
- ₹228.40 / ₹229.23
- Market Cap
- ₹302.77 Bil
- Volume/Avg
- 8.1 Mil / 8.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- 224.50
- Price/Sales
- 3.61
- Dividend Yield (Trailing)
- 0.05%
- Dividend Yield (Forward)
- 0.05%
- Total Yield
- 0.05%
Company Profile
Piramal Pharma Ltd is a pharmaceutical company, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and international distribution network. It operates under three business verticals; an integrated contract development and manufacturing (CDMO) business providing Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), biologics, and vaccines among other products; the other two business verticals include a complex hospital generics business, and an India consumer healthcare business, selling over-the-counter products in India. Geographically, the company generates maximum revenue from North America and the rest from Europe, India, Japan, and other markets.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 7,933
- Website
- https://www.piramal.com
Comparables
Valuation
|
Metric
|
PPLPHARMA
|
MARKSANS
|
AUROPHARMA
|
|---|---|---|---|
Price/Earnings (Normalized) | 224.50 | 39.46 | 23.96 |
Price/Book Value | 3.82 | 6.36 | 2.88 |
Price/Sales | 3.61 | 5.80 | 2.92 |
Price/Cash Flow | 38.25 | 37.37 | 22.26 |
Price/Earnings
PPLPHARMA
MARKSANS
AUROPHARMA
Financial Strength
|
Metric
|
PPLPHARMA
|
MARKSANS
|
AUROPHARMA
|
|---|---|---|---|
Quick Ratio | 0.61 | 2.99 | 0.96 |
Current Ratio | 1.25 | 4.78 | 1.98 |
Interest Coverage | 1.53 | 33.90 | 15.28 |
Quick Ratio
PPLPHARMA
MARKSANS
AUROPHARMA
Profitability
|
Metric
|
PPLPHARMA
|
MARKSANS
|
AUROPHARMA
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
PPLPHARMA
MARKSANS
AUROPHARMA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Bqcdvdhlmz | Szgxh | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Jcyczyyvm | Wwwtlw | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Nlxhyzhv | Jzmt | $45.9 Bil | |||
| Viatris Inc
VTRS
| Fchcjpsn | Ztvq | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Jmtlgjzv | Lmkh | $13.2 Bil | |||
| Catalent Inc
CTLT
| Mdsvhzc | Tlpqys | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Qxlpsqntr | Qjmygld | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Jrhklcgr | Txj | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Dzgpwbpzgj | Ywq | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Ltpdjwz | Gxys | $2.2 Bil |
United States